Brief: Altamira Says SemaPhore Platform Shown Effective In Intracellular mRNA Delivery For Cancer Therapy
19/07/2022 14:46
July 19 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTIC'S SEMAPHORE PLATFORM SHOWN
PARTICULARLY
EFFECTIVE IN INTRACELLULAR MRNA DELIVERY FOR CANCER THERAPY
Source text for Eikon: ID:nGNX4fZzb0
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering